{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P46098",
      "entity_text" : "5-HT 3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0158" ],
      "Organ" : [ "uberon:UBERON:0000062" ],
      "CellType" : [ "cl:CL:0000097" ],
      "Species" : [ "taxonomy:10116" ]
    }
  },
  "verbose_text" : "Clinical studies showed that 5-HT and 5-HT 3 expression levels were markedly increased in the intestinal mucosa among patients with IBS; the application of a 5-HT3 receptor antagonist improved the threshold value of colonic CRD [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-08T16:31:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T16:21:33Z",
  "trigger" : "levels",
  "evidence" : [ "5-HT 3  expression levels" ],
  "pmc_id" : "5294365",
  "score" : 0
}